X
22Mar

Impacts of Covid-19 on Closing M&A Transactions

The World Health Organization declared the outbreak of the novel coronavirus disease (COVID-19) a pandemic, prompting numerous public and private organizations and agencies to accelerate their contingency plans so as to mitigate continued...
By: Sheppard Mullin Richter & Hampton LLP
Source Url: https://www.jdsupra.com/legalnews/impacts-of-covid-19-on-closing-m-a-29541/

Related

Consonance Capital Partners to Sell Enclara Healthcare to Humana

Consonance Capital Partners (CCP) has announced it will sell Enclara Healthcare to Humana. Enclara,...

Read More >

Connecticut Enacts Sweeping Legislation Addressing Workplace Harassment

Joining the ranks of New York and California, Connecticut has adopted legislation that significantly...

Read More >

EEOC Sets New Deadline for EEO-1 Component 2 Reporting

Over the past weeks, I’ve written a few times on the ongoing requirements and changing deadlines of...

Read More >

March 31 Deadline to Amend 403(b) Retirement Plans Approaches

Employer sponsors of 403(b) retirement plans have until March 31, 2020, to amend their plan document...

Read More >

European Competition Law Newsletter – May 2020

EU, UK Competition, State Aid and Public Procurement Law During COVID-19 - While not the most impor...

Read More >

Federal District Court Dismisses Pension Actuarial Equivalence Lawsuit

A federal district court recently handed plan sponsors their first victory in a string of actuarial ...

Read More >